☆ 4.6 Letter

Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome?

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2022)

Journal

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Volume 55, Issue 1, Pages 170-171

Publisher

ELSEVIER TAIWAN

DOI: 10.1016/j.jmii.2021.07.016

Keywords

COVID-19; Steroid; Hypoxia; Dexamethasone

Categories

Immunology Infectious Diseases Microbiology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.